Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market to Reach 25 Billion by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market to Reach 25 Billion by 2024

Description:

The Attention Deficit Hyperactivity Disorder Therapeutics market is expected to exceed more than US$ 25 Billion by 2024; Growing at a CAGR of more than 6% in the given forecast period. – PowerPoint PPT presentation

Number of Views:86
Slides: 12
Provided by: wamy156

less

Transcript and Presenter's Notes

Title: Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market to Reach 25 Billion by 2024


1
Attention Deficit Hyperactivity Disorder (ADHD)
Therapeutics Market Research Report
  • Presented By
  • Market Research Engine
  • https//www.marketresearchengine.com/

2
Report TitleAttention Deficit Hyperactivity
Disorder (ADHD) Therapeutics Market to Reach 25
Billion by 2024 - by Market Research Engine
3
  • New York, January 31 Market Research Engine has
    published a new report titled as Attention
    Deficit Hyperactivity Disorder Therapeutics
    Market By Drug Type (Non-stimulants, Stimulants),
    By Age Group (Adults, Pediatric and Adolescent)
    and By Distribution Channel (Specialty Clinics,
    Hospital Pharmacies, Retail Pharmacies,
    e-Commerce) Global Industry Analysis and
    Forecast by 2024
  •  
  • How Big is the Attention Deficit Hyperactivity
    Disorder Therapeutics market?The Attention
    Deficit Hyperactivity Disorder Therapeutics
    market is expected to exceed more than US 25
    Billion by 2024 Growing at a CAGR of more than
    6 in the given forecast period.
  • Download Free Sample Report https//www.marketres
    earchengine.com/requestsample/attention-deficit-hy
    peractivity-disorder-therapeutics-market
  • Attention deficit hyperactivity disorder
    therapeutics is a neuro developmental disorder
    described by impairing and pervasive symptoms of
    impulsivity, hyperactivity, and inattention.

4
  • The core for disease control and prevention
    defines neurobehavioral because the way the brain
    affects learning, behavior and emotion.
    Development in the ADHD therapeutics market is
    mostly driven by granular impact of varying
    lifestyles and value scheme impacting value of
    births increasing use of preservation's and
    additives in childrens diet increasing
    prevalence of ADHD within the 4 to 17 year age
    group rising acceptance of diagnostic of
    guidelines with low threshold for designation of
    syndrome in alternative regions like Europe and
    geographical region. Moreover, increasing
    awareness concerning syndrome among physicians
    and patients, and opinion based as a result of
    lack of normal diagnostic tests is anticipated to
    spice up revenue growth of the worldwide syndrome
    medicine market within the close to future.The
    attention deficit hyperactivity disorder
    therapeutics market is segmented on the lines of
    its drug type, age group, distribution channel
    and regional. Drugs type is further divided into
    non stimulants and stimulants. Under non
    stimulants segmentation the market covers
    atomoxetine, bupropion, guanfacine and clonidine.
    Under stimulants segmentation it covers
    amphetamine, methylphenidate, dextroamphetamine,
    dexmethylphenidate, lisdexamfetamine and
    dimesylate. Based on age group segmentation it
    covers pediatric and adolescent and adults. The
    attention deficit hyperactivity disorder
    therapeutics market is segmented on the lines of
    its distribution channel like specialty clinics,
    hospital pharmacies, retail pharmacies and
    e-commerce.

5
  • The attention deficit hyperactivity disorder
    therapeutics markets geographic segmentation
    covers various regions such as North America,
    Europe, Asia Pacific, Latin America, Middle East
    and Africa. Each geographic market is further
    segmented to provide market revenue for select
    countries such as the U.S., Canada, U.K. Germany,
    China, Japan, India, Brazil, and GCC countries.
  • Browse Full Report https//www.marketresearchengi
    ne.com/reportdetails/attention-deficit-hyperactivi
    ty-disorder-therapeutics-market
  • This report provides1) An overview of the
    global market for attention deficit hyperactivity
    disorder therapeutics and related technologies.
  • 2) Analyses of global market trends, with data
    from 2013, estimates for 2014 and 2015, and
    projections of compound annual growth rates
    (CAGRs) through 2024.

6
  • 3) Identifications of new market opportunities
    and targeted promotional plans for attention
    deficit hyperactivity disorder therapeutics.
  • 4) Discussion of research and development, and
    the demand for new products and new
    applications.
  • 5) Comprehensive company profiles of major
    players in the industry. REPORT SCOPE
  • The scope of the report includes a detailed study
    of global and regional markets for Attention
    deficit hyperactivity disorder (ADHD)
    therapeutics market for variations in the growth
    of the industry in certain regions.
  • The report covers detailed competitive outlook
    including the market share and company profiles
    of the key participants operating in the global
    market.

7
  • Key players profiled in the report include Eli
    Lilly and Company, Novartis AG, Shire PLC,
    Pfizer, Inc., GlaxoSmithKline PLC, Mallinckrodt
    Pharmaceuticals, Hisamitsu Pharmaceutical Co.,
    Inc., Impax Laboratories, Inc., Johnson
    Johnson, UCB S.A., and Purdue Parma L.P. Company
    profile includes assign such as company summary,
    financial summary, business strategy and
    planning, SWOT analysis and current developments.
    The Top Companies Report is intended to provide
    our buyers with a snapshot of the industrys most
    influential players. The Attention Deficit
    Hyperactivity Disorder Therapeutics Market has
    been segmented as below  
  • By Drug Type Analysis    Non-stimulants  
     Atomoxetine    Bupropion

8
  • Guanfacine    Clonidine    Stimulants  
     Amphetamine    Methylphenidate  
     Dextroamphetamine    Dexmethylphenidate  
     Lisdexamfetamine    DimesylateBy Age Group
    Analysis    Pediatric and Adolescent    Adults
  • By Distribution Channel Analysis

9
  • Specialty Clinics    Hospital Pharmacies  
     Retail Pharmacies    e-CommerceBy Regional
    Analysis    North America    Europe  
     Asia-Pacific    Rest of the World
  • Reasons to Buy this Report1) Obtain the most
    up to date information available on all attention
    deficit hyperactivity disorder therapeutics.
  • 2) Identify growth segments and opportunities in
    the industry.

10
  • 3) Facilitate decision making on the basis of
    strong historic and forecast of attention deficit
    hyperactivity disorder therapeutics data.
  • 4) Assess your competitors refining portfolio
    and its evolution.
  • Check out other Research Reports
  • Food Service Equipment Market By Product Segment
    Analysis (Ice cream machines, Blast freezers,
    Commercial fridges/ freezers, Glass door
    merchandisers, Beverage dispensers, Refrigerated
    vending machines) - Global Industry Analysis and
    Forecast 2016 - 2022 https//www.marketresearcheng
    ine.com/reportdetails/food-service-equipment-marke
    t
  • Healthcare/Medical Simulation Market by Product
    Services (Surgical Simulator, Patient
    Simulator, Task Trainers, Web-based Simulation,
    Software, Dental Simulator, Eye Simulator), End
    User (Hospital, Military and Academics) - Global
    Industry Analysis and Forecast 2016 - 2022
    https//www.marketresearchengine.com/reportdetails
    /healthcare-medical-simulation-market

11
  • About Market Research Engine
  • Market Research Engine is a global market
    research and consulting organization. We provide
    market intelligence in emerging, niche
    technologies and markets. Our market analysis
    powered by rigorous methodology and quality
    metrics provide information and forecasts across
    emerging markets, emerging technologies and
    emerging business models. Our deep focus on
    industry verticals and country reports help our
    clients to identify opportunities and develop
    business strategies.
  • More info https//www.marketresearchengine.com/
  • Media Contact
  • Name John Bay
  • Toll Free No. 1-855-984-1862
  • Phone 91-860-565-7204
  • Email john_at_marketresearchengine.com
  • Website https//www.marketresearchengine.com/
Write a Comment
User Comments (0)
About PowerShow.com